M CAREOS
0809.835.776 · rovalta.com · 23/09/2026
M CAREOS
Overview
What does M CAREOS do?
M CAREOS is a Private limited company incorporated in 2009. Its main activity is: General medical practice activities. Its registered office is in Binche.
7133 Binche · WallonieSee on map
Trend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Gross margin | 230,3 k € | +24.5% | 185 k € | -6.3% | 197,4 k € | +23.3% | 160,1 k € | -10.5% | 179 k € | +14.3% | 156,6 k € | +8.9% | 143,8 k € | +3.9% | 138,4 k € | +26.6% | 109,3 k € | -22.3% | 140,7 k € | +48.9% | 94,5 k € | +13.6% | 83,2 k € | +93.2% | 43,1 k € | -26.5% | 58,6 k € | +15.8% | 50,6 k € | +33.4% | 37,9 k € | -10.8% | 42,5 k € |
| EBITDA | 229,6 k € | +24.3% | 184,8 k € | -6.3% | 197,1 k € | +23.7% | 159,3 k € | -10.6% | 178,1 k € | +14.6% | 155,4 k € | +8.8% | 142,8 k € | +3.5% | 137,9 k € | +28.0% | 107,8 k € | -23.0% | 140 k € | +49.8% | 93,4 k € | +13.3% | 82,5 k € | +94.8% | 42,3 k € | -26.5% | 57,6 k € | +15.8% | 49,7 k € | +33.6% | 37,2 k € | -9.5% | 41,1 k € |
| Operating result | 217,9 k € | +26.1% | 172,7 k € | -10.5% | 193 k € | +22.0% | 158,2 k € | -8.6% | 173,2 k € | +15.4% | 150,1 k € | +9.1% | 137,5 k € | +15.5% | 119 k € | +34.0% | 88,8 k € | -29.1% | 125,3 k € | +59.1% | 78,8 k € | +17.3% | 67,2 k € | +202% | 22,2 k € | -40.6% | 37,4 k € | +30.3% | 28,7 k € | +63.7% | 17,6 k € | -18.3% | 21,5 k € |
| Net result | 152,9 k € | +20.9% | 126,5 k € | -8.8% | 138,7 k € | +21.1% | 114,6 k € | -6.9% | 123,1 k € | +15.8% | 106,3 k € | +0.8% | 105,5 k € | +14.3% | 92,3 k € | +54.5% | 59,7 k € | -27.4% | 82,3 k € | +34.0% | 61,4 k € | +43.3% | 42,9 k € | +109% | 20,5 k € | -2.5% | 21 k € | +517% | -5 k € | -165% | 7,7 k € | -32.8% | 11,5 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | 880,3 k € | +18.1% | 745,4 k € | +17.7% | 633,4 k € | +20.7% | 524,7 k € | +12.3% | 467,1 k € | +27.8% | 365,5 k € | +34.8% | 271,2 k € | +38.6% | 195,7 k € | +21.2% | 161,4 k € | +5.7% | 152,7 k € | +60.1% | 95,4 k € | +59.1% | 59,9 k € | +5.0% | 57,1 k € | +56.1% | 36,6 k € | +37.8% | 26,5 k € | -16.0% | 31,6 k € | +32.3% | 23,9 k € |
| Total assets | 975,8 k € | +11.3% | 877 k € | +6.5% | 823,4 k € | +35.9% | 605,7 k € | +21.8% | 497,2 k € | +31.1% | 379,3 k € | +35.2% | 280,5 k € | +11.4% | 251,8 k € | +42.0% | 177,3 k € | +2.2% | 173,5 k € | +22.5% | 141,7 k € | +14.9% | 123,3 k € | +3.1% | 119,5 k € | -13.7% | 138,6 k € | -0.8% | 139,7 k € | -19.1% | 172,5 k € | -11.2% | 194,2 k € |
| Cash | 109 k € | +179% | 39,1 k € | +42.5% | 27,4 k € | -27.3% | 37,7 k € | -91.5% | 446,2 k € | +19.5% | 373,3 k € | +50.4% | 248,2 k € | +19.7% | 207,4 k € | +53.6% | 135 k € | +4.7% | 128,9 k € | +56.7% | 82,3 k € | +72.1% | 47,8 k € | +88.2% | 25,4 k € | +61.2% | 15,8 k € | +12.5% | 14 k € | -66.4% | 41,7 k € | +27.3% | 32,7 k € |
| Debts | 95,5 k € | -27.4% | 131,6 k € | -30.7% | 189,9 k € | +134% | 81 k € | +169% | 30,2 k € | +118% | 13,8 k € | +49.1% | 9,3 k € | -83.5% | 56 k € | +253% | 15,9 k € | -23.6% | 20,8 k € | -55.1% | 46,3 k € | -26.9% | 63,3 k € | +1.4% | 62,5 k € | -38.8% | 102 k € | -9.8% | 113,1 k € | -19.7% | 140,9 k € | -17.0% | 169,8 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 02/09/2026 | 23/09/2025 | 30/09/2024 | 15/07/2023 | 01/09/2022 | 24/06/2021 |
| General meeting | 08/06/2026 | 10/06/2025 | 10/06/2024 | 12/06/2023 | 13/06/2022 | 14/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
17 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 08/06/2026 | 02/09/2026 | French | |
| Micro model | 31/12/2024 | 10/06/2025 | 23/09/2025 | French | |
| Micro model | 31/12/2023 | 10/06/2024 | 30/09/2024 | French | |
| Abridged model | 31/12/2022 | 12/06/2023 | 15/07/2023 | French | |
| Abridged model | 31/12/2021 | 13/06/2022 | 01/09/2022 | French | |
| Abridged model | 31/12/2020 | 14/06/2021 | 24/06/2021 | French | |
| Abridged model | 31/12/2019 | 08/06/2020 | 14/09/2020 | French | |
| Abridged model | 31/12/2018 | 11/06/2019 | 01/07/2019 | French | |
| Abridged model | 31/12/2017 | 11/06/2018 | 02/07/2018 | French | |
| Abridged model | 31/12/2016 | 12/06/2017 | 27/06/2017 | French | |
| Abridged model | 31/12/2015 | 13/06/2016 | 30/06/2016 | French | |
| Abridged model | 31/12/2014 | 08/06/2015 | 17/09/2015 | French | |
| Abridged model | 31/12/2013 | 10/06/2014 | 30/06/2014 | French | |
| Abridged model | 31/12/2012 | 10/06/2013 | 24/06/2013 | French | |
| Abridged model | 31/12/2011 | 11/06/2012 | 02/07/2012 | French | |
| Abridged model | 31/12/2010 | 14/06/2011 | 30/06/2011 | French | |
| Abridged model | 31/12/2009 | 14/06/2010 | 09/07/2010 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025152,9 k €↑
- 2024Annual accounts 2024126,5 k €↓
- 2023Annual accounts 2023138,7 k €↑
- 2023Name changeM CAREOS
- 2022Annual accounts 2022114,6 k €↓
- 2021Annual accounts 2021123,1 k €↑
- 2021Name changeCAMELIA ROSSI (soc médicale) sprlu
- 2020Annual accounts 2020106,3 k €↑
- 2019Annual accounts 2019105,5 k €↑
- 2018Annual accounts 201892,3 k €↑
- 2017Annual accounts 201759,7 k €↓
- 2016Annual accounts 201682,3 k €↑
- 2015Annual accounts 201561,4 k €↑
- 2014Annual accounts 201442,9 k €↑
- 2013Annual accounts 201320,5 k €↓
- 2012Annual accounts 201221 k €↑
- 2011Annual accounts 2011-5 k €↓
- 2010Annual accounts 20107,7 k €↓
- 2009Annual accounts 200911,5 k €
- 16/02/2009IncorporationPrivate limited company